The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis

Journal of Biomedical Science

Volumn 16, Issue , 2009, Pages

  Puddu, Paolo ^a   Puddu, Giovanni M ^a   Cravero, Eleonora ^a   De Pascalis, Susanna ^a   Muscari, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Homocysteine; Mitochondrial Dysfunction; Nitric Oxide; Reactive Oxygen Species; Reactive Oxygen Species Production

Indexed keywords

ANTIOXIDANT; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ANIMAL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHEMISTRY; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; MACROPHAGE; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DNA, MITOCHONDRIAL; DYSLIPIDEMIAS; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; MACROPHAGES; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 76249124669     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-112     Document Type: Review

References (154)

1. Puddu GM, Cravero E, Arnone G, Muscari A, Puddu P: Molecular aspects of atherogenesis: new insights and unsolved questions. J Biomed Sci 2005, 12:839-853.
2. Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
3. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM: The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004, 45:993-1007.
4. Madamanchi NR, Vendrov A, Runge MS: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
5. Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, Heinecke JW: The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1dependent cholesterol transport. Proc Natl Acad Sci USA 2004, 101:13032-13037.
6. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
7. Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996, 20:707-727.
8. Freeman BA, White CR, Gutierrez H, Paler-Martínez A, Tarpey MM, Rubbo H: Oxygen radical-nitric oxide reactions in vascular diseases. Adv Pharmacol 1995, 34:45-69.
9. Victor VM, Rocha M, Solá E, Bañuls C, Garcia-Malpartida K, Hernández-Mijares A: Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009, 15:2988-3002.
10. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
11. Alexander RW: Atherosclerosis as disease of redox-sensitive genes. Trans Am Clin Climatol Assoc 1998, 109:129-145.
12. Ito H, Torii M, Suzuki T: Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 1995, 17:803-816.
13. van Jaarsveld H, Kuyl JM, Alberts DW: Exposure of rats to low concentration of cigarette smoke increases myocardial sensitivity to ischaemia/reperfusion. Basic Res Cardiol 1992, 87:393-399.
14. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC: Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 1999, 96:4820-4825.
15. Wallace DC: Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992, 256:628-632.
16. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, Runge MS: Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-349.
17. Ballinger SW: Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005, 38:1278-1295.
18. Madamanchi NR, Runge MS: Mitochondrial dysfunction in atherosclerosis. Circ Res 2007, 100:460-473.
19. Puddu P, Puddu GM, Galletti L, Cravero E, Muscari A: Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology 2005, 103:137-141.
20. Pourova J, Kottova M, Voprsalova M, Pour M: Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol (Oxf) 2009 in press.
21. Pieczenik SR, Neustadt J: Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 2007, 83:84-92.
22. Wallace DC: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005, 39:359-407.
23. Green K, Brand MD, Murphy MP: Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004, 53(Suppl 1):S110-S118.
24. Zhang DX, Gutterman DD: Mitochondrial reactive oxygen species mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 2007, 292:2023-2031.
25. Li JM, Shah AM: Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004, 287:1014-1030.
26. Mueller CF, Laude K, McNally JS, Harrison DG: ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 2005, 25:274-278.
27. Davidson SM, Duchen MR: Endothelial mitochondria: contributing to vascular function and disease. Circ Res 2007, 100:1128-1141.
28. O'Malley Y, Fink BD, Ross NC, Prisinzano TE, Sivitz WI: Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem 2006, 281:39766-39775.
29. Klatt P, Lamas S: Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000, 267:4928-4944.
30. Ridnour LA, Thomas DD, Mancardi D, Espey MG, Miranda KM, Paolocci N, Feelisch M, Fukuto J, Wink DA: The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 2004, 385:1-10.
31. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A: Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 2006, 99:924-932.
32. Cooper CE, Patel RP, Brookes PS, Darley-Usmar VM: Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem Sci 2002, 27:489-492.
33. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H: Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A-11A.
34. Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
35. Dröge W: Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
36. Scarpulla RC: Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 2006, 97:673-683.
37. Teshima Y, Akao M, Jones SP, Marbán E: Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 2003, 93:192-200.
38. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000, 26:435-439.
39. Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS, Lee WJ, Koh EH, Song KH, Han SM, Kim MS, Park IS, Park JY: Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 2005, 96:1200-1207.
40. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, Harper JA, Roebuck SJ, Morrison A, Pickering S, Clapham JC, Brand MD: Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415:96-99.
41. Brand MD, Esteves TC: Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2005, 2:85-93.
42. Villarroya F, Iglesias R, Giralt M: PPARs in the Control of Uncoupling Proteins Gene Expression. PPAR Res 2007, 2007:74364.
43. Puddu P, Puddu GM, Muscari A: Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression? Int J Cardiol 2003, 90:133-140.
44. Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W: From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 2006, 45:120-159.
45. Nunn AV, Bell J, Barter P: The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nucl Recept 2007, 5:1.
46. Duchen MR: Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 2004, 25:365-451.
47. Andreyev AY, Kushnareva YE, Starkov AA: Mitochondrial metabolism of reactive oxygen species. Biochemistry 2005, 70:200-214.
48. Adam-Vizi V, Chinopoulos C: Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006, 27:639-645.
49. James AM, Murphy MP: How mitochondrial damage affects cell function. J Biomed Sci 2002, 9:475-487.
50. Schönfeld P, Wojtczak L: Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta 2007, 1767:1032-1040.
51. Lacza Z, Pankotai E, Csordás A, Gero D, Kiss L, Horváth EM, Kollai M, Busija DW, Szabó C: Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? Nitric Oxide 2006, 14:162-168.
52. Ghafourifar P, Richter C: Nitric oxide synthase activity in mitochondria. FEBS Lett 1997, 418:291-296.
53. Giulivi C, Poderoso JJ, Boveris A: Production of nitric oxide by mitochondria. J Biol Chem 1998, 273:11038-11043.
54. Ghafourifar P, Cadenas E: Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 2005, 26:190-195.
55. Lacza Z, Lacza Z, Kozlov AV, Pankotai E, Csordás A, Wolf G, Redl H, Kollai M, Szabó C, Busija DW, Horn TF: Mitochondria produce reactive nitrogen species via an arginine-independent pathway. Free Radic Res 2006, 40:369-378.
56. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991, 288:481-487.
57. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS: Hydrogen peroxide-and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000, 86:960-966.
58. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271:1424-437.
59. Cassina A, Radi R: Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996, 328:309-316.
60. Radi R, Cassina A, Hodara R: Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002, 383:401-409.
61. Dahm CC, Moore K, Murphy MP: Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J Biol Chem 2006, 281:10056-10065.
62. Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, Täger M, Bode-Böger SM: Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler Thromb Vasc Biol 2004, 24:1816-1822.
63. Sud N, Wells SM, Sharma S, Wiseman DA, Wilham J, Black SM: Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am J Physiol Cell Physiol 2008, 294:C1407-C1418.
64. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG: Electron transfer between cyto chrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
65. Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I, Pelliccia G, Trinei M, Bono M, Puri C, Tacchetti C, Ferrini M, Mannucci R, Nicoletti I, Lanfrancone L, Giorgio M, Pelicci PG: The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 2004, 279:25689-5695.
66. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG: The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
67. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P: Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 2003, 100:2112-2126.
68. Croteau DL, Bohr VA: Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 1997, 272:25409-25412.
69. Van Remmen H, Hamilton ML, Richardson A: Oxidative damage to DNA and aging. Exerc Sport Sci Rev 2003, 36:149-153.
70. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, Prolla TA: Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
71. Halliwell B, Aruoma OI: DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 1991, 281:9-19.
72. Grollman AP, Moriya M: Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 1993, 9:246-249.
73. Bohr VA: Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 2002, 32:804-812.
74. Stuart JA, Bourque BM, de Souza-Pinto NC, Bohr VA: No evidence of mitochondrial respiratory dysfunction in OGG1-null mice deficient in removal of 8-oxodeoxyguanine from mitochondrial DNA. Free Radic Biol Med 2005, 38:737-745.
75. Stuart JA, Brown MF: Mitochondrial DNA maintenance and bioenergetics. Biochim Biophys Acta 2006, 1757:79-89.
76. Wei YH, Lu CY, Lee HC, Pang CY, Ma YS: Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci 1998, 854:155-170.
77. Mikaelian NP, Khalilov EM, Ivanov AS, Fortinskaia ES, Lopukhin IuM: Mitochondrial enzymes in circulating lymphocytes during hemosorption for experimental hypercholesterolemia. Biull Eksp Biol Med 1983, 96:35-37.
78. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, Ischiropoulos H, Ballinger SW: Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002, 105:849-854.
79. Yao PM, Tabas I: Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 2001, 276:42468-42476.
80. Tabas I: Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002, 110:905-911.
81. Schmitz G, Grandl M: Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid Redox Signal 2007, 9:1499-1518.
82. Raha S, Robinson BH: Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 2001, 106:62-70.
83. Sato T, Machida T, Takahashi S, Iyama S, Sato Y, Kuribayashi K, Takada K, Oku T, Kawano Y, Okamoto T, Takimoto R, Matsunaga T, Takayama T, Takahashi M, Kato J, Niitsu Y: Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 2004, 173:285-296.
84. Cheng J, Cui R, Chen CH, Du J: Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells. Endocrinology 2007, 148:2085-2094.
85. Fleming I, Mohamed A, Galle J, Turchanowa L, Brandes RP, Fisslthaler B, Busse R: Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 2005, 65:897-906.
86. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
87. Vindis C, Elbaz M, Escargueil-Blanc I, Augé N, Heniquez A, Thiers JC, Nègre-Salvayre A, Salvayre R: Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDLinduced apoptosis. Arterioscler Thromb Vasc Biol 2005, 25:639-645.
88. Mallat Z, Tedgui A: Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 2000, 130:947-962.
89. Geng YJ, Libby P: Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002, 22:1370-1380.
90. Hayden MR, Sowers JR: Redox imbalance in diabetes. Antioxid Redox Signal 2007, 9:865-867.
91. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR, Curi R: Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007, 583:9-24.
92. Mehta JL, Rasouli N, Sinha AK, Molavi B: Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol 2006, 38:794-803.
93. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
94. Azevedo-Martins AK, Monteiro AP, Lima CL, Lenzen S, Curi R: Fatty acid-induced toxicity and neutral lipid accumulation in insulin-producing RINm5F cells. Toxicol In Vitro 2006, 20:1106-1113.
95. McGarry JD: Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51:7-18.
96. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
97. Haber EP, Procópio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R: New insights into fatty acid modulation of pancreatic beta-cell function. Int Rev Cytol 2006, 248:1-41.
98. Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53:1412-1417.
99. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI: Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007, 56:1376-1381.
100. McBride HM, Neuspiel M, Wasiak S: Mitochondria: more than just a powerhouse. Curr Biol 2006, 16:551-560.
101. Romero JC, Reckelhoff JF: State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999, 34:943-949.
102. Raij L: Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 1998, 31:189-193.
103. Redón J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sáez GT: Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41:1096-1101.
104. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998, 16:1267-1271.
105. Paravicini TM, Touyz RM: Redox signaling in hypertension. Cardiovasc Res 2006, 71:247-258.
106. McIntyre M, Bohr DF, Dominiczak AF: Endothelial function in hypertension: the role of superoxide anion. Hypertension 1999, 34:539-5345.
107. Ward NC, Croft KD: Hypertension and oxidative stress. Clin Exp Pharmacol Physiol 2006, 33:872-876.
108. Kumar KV, Das UN: Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993, 19:59-66.
109. Chan SH, Wu KL, Chang AY, Tai MH, Chan JY: Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 2009, 53:217-227.
110. Brookes PS, Levonen AL, Shiva S, Sarti P, Darley-Usmar VMS, Levonen AL, Shiva S, Sarti P, Darley-Usmar VM: Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 2002, 33:755-764.
111. Atlante A, Seccia TM, Pierro P, Vulpis V, Marra E, Pirrelli A, Passarella S: ATP synthesis and export in heart left ventricle mitochondria from spontaneously hypertensive rat. Int J Mol Med 1998, 1:709-716.
112. Bernal-Mizrachi C, Gates AC, Weng S, Imamura T, Knutsen RH, DeSantis P, Coleman T, Townsend RR, Muglia LJ, Semenkovich CF: Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature 2005, 435:502-506.
113. Postnov IuV: The role of mitochondrial calcium overload and energy deficiency in pathogenesis of arterial hypertension. Arkh Patol 2001, 63:3-10.
114. Chen L, Tian X, Song L: Biochemical and biophysical characteristics of mitochondria in the hypertrophic hearts from hypertensive rats. Chin Med J (Engl) 1995, 108:361-366.
115. Seccia TM, Atlante A, Vulpis V, Marra E, Passarella S, Pirrelli A: Abnormal transport of inorganic phosphate in left ventricular mitochondria from spontaneously hypertensive rats. Cardiologia 1999, 44:719-725.
116. Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M, Ohishi M, Katsuya T, Rakugi H, Ogihara T: A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens 2004, 22:97-102.
117. Rachek LI, Grishko VI, Ledoux SP, Wilson GL: Role of nitric oxideinduced mtDNA damage in mitochondrial dysfunction and apoptosis. Free Radic Biol Med 2006, 40:754-762.
118. Watson B Jr, Khan MA, Desmond RA, Bergman S: Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am J Kidney Dis 2001, 38:529-536.
119. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP: A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004, 306:1190-1194.
120. Puddu P, Puddu GM, Cravero E, De Pascalis S, Muscari A: The putative role of mitochondrial dysfunction in hypertension. Clin Exp Hypertens 2007, 29:427-434.
121. McCully KS: Homocysteine and vascular disease. Nat Med 1996, 2:386-389.
122. Duell PB, Malinow MR: Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol 1997, 8:28-34.
123. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999, 100:1161-1168.
124. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS: Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 2000, 279:671-678.
125. Austin RC, Sood SK, Dorward AM, Singh G, Shaughnessy SG, Pamidi S, Outinen PA, Weitz JI: Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. Homocysteine and H2O2 act synergistically to enhance mitochondrial damage. J Biol Chem 1998, 273:30808-30817.
126. Tyagi N, Ovechkin AV, Lominadze D, Moshal KS, Tyagi SC: Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J Cell Biochem 2006, 98:1150-1162.
127. Lee SJ, Kim KM, Namkoong S, Kim CK, Kang YC, Lee H, Ha KS, Han JA, Chung HT, Kwon YG, Kim YM: Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 2005, 280:5781-5788.
128. Masayesva BG, Mambo E, Taylor RJ, Goloubeva OG, Zhou S, Cohen Y, Minhas K, Koch W, Sciubba J, Alberg AJ, Sidransky D, Califano J: Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev 2006, 15:19-24.
129. Miró O, Alonso JR, Jarreta D, Casademont J, Urbano-Márquez A, Cardellach F: Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999, 20:1331-1336.
130. Eaton MM, Gursahani H, Arieli Y, Pinkerton K, Schaefer S: Acute tobacco smoke exposure promotes mitochondrial permeability transition in rat heart. J Toxicol Environ Health A 2006, 69:1497-1510.
131. Yang Z, Knight CA, Mamerow MM, Vickers K, Penn A, Postlethwait EM, Ballinger SW: Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/-mice fed a chow diet. Circulation 2004, 110:3715-20.
132. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, Greenberg AE, Janssen RS, HIV Outpatient Study (HOPS) investigators: Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002, 360:1747-1748.
133. Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD, DAD study group: Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS 2003, 17:1179-1193.
134. Jericó C, Knobel H, Calvo N, Sorli ML, Guelar A, Gimeno-Bayón JL, Saballs P, López-Colomés JL, Pedro-Botet J: Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke 2006, 37:812-817.
135. Harrison DG: Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997, 100:2153-2157.
136. Luft R, Landau BR: Mitochondrial medicine. J Intern Med 1995, 238:405-421.
137. Han D, Williams E, Cadenas E: Mitochondrial respiratory chaindependent generation of superoxide anion and its release into the intermembrane space. Biochem J 2001, 353:411-416.
138. Barja G, Herrero A: Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J Bioenerg Biomembr 1998, 30:235-243.
139. Cohen G, Kesler N: Monoamine oxidase and mitochondrial respiration. J Neurochem 1999, 73:2310-2315.
140. Ballinger SW, Bouder TG, Davis GS, Judice SA, Nicklas JA, Albertini RJ: Mitochondrial genome damage associated with cigarette smoking. Cancer Res 1996, 56:5692-5697.
141. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
142. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP: Randomised trial of alpha-tocopherol and betacarotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997, 349:1715-1720.
143. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:154-160.
144. Matthews RT, Yang L, Browne S, Baik M, Beal MF: Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998, 5:8892-8897.
145. Lass A, Sohal RS: Electron transport-linked ubiquinonedependent recycling of alpha-tocopherol inhibits autooxidation of mitochondrial membranes. Arch Biochem Biophys 1998, 352:229-236.
146. Victor VM, Rocha M, De la Fuente M: N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 2003, 37:919-929.
147. Victor VM, Rocha M, De la Fuente M: Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004, 4:327-347.
148. Victor VM, Rocha M, Esplugues JV, De la Fuente M: Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005, 11:3141-3158.
149. Kagan VE, Serbinova EA, Stoyanovsky DA, Khwaja S, Packer L: Assay of ubiquinones and ubiquinols as antioxidants. Methods Enzymol 1994, 234:343-354.
150. Armstrong JS: Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 2007, 151:1154-1165.
151. Murphy MP, Smith RA: Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007, 47:629-656.
152. 10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy. Hypertension 2009, 54:322-328.
153. Gane EJ, Orr DW, Weilert F, Keogh GF, Gibson M, Murphy MP, Smith RAJ, Lockhart MM, Frampton CM, Taylor KM: Phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C [abstract]. J Hepatol 2008, 48:S318.
154. Snow BJ, Rolfe FL, Murphy MP, Smith RA, Lockhart MM, Frampton CM, Taylor KM: Phase II study of the mitochondrial antioxidant mitoquinone for Parkinson's disease. Neurology 2008, 70:A483-A484.